Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis

Open Access

Peer-reviewed

Research Article

Steffie K. Naber ,

* E-mail: s.naber@erasmusmc.nl

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯
Suzette M. Matthijsse,

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯
Kirsten Rozemeijer,

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯
Corine Penning,

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯
Inge M. C. M. de Kok,

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯
Marjolein van Ballegooijen

Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
⨯

Reader Comments (0)

Immunity
Is the Subject Area "Immunity" applicable to this article?

Thanks for your feedback.
Cervical cancer
Is the Subject Area "Cervical cancer" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Human papillomavirus
Is the Subject Area "Human papillomavirus" applicable to this article?

Thanks for your feedback.
Cancer vaccines
Is the Subject Area "Cancer vaccines" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer screening
Is the Subject Area "Cancer screening" applicable to this article?

Thanks for your feedback.